Safety of ocrelizumab in multiple sclerosis: updated analysis in patients with relapsing and primary progressive multiple sclerosis

被引：0
|
作者：
Hauser, S. L. [1 ]
Kappos, L. [2 ]
Montalban, X. [3 ]
Guittari, C. J. [4 ]
Koendgen, H. [5 ]
Li, C. [5 ]
Marcillat, C. [5 ]
Wormser, D. [5 ]
Wolinsky, J. S. [6 ]
机构：
[1] Univ Calif San Francisco, San Francisco, CA 94143 USA
[2] Univ Basel, Univ Hosp Basel, Basel, Switzerland
[3] Vall dHebron Univ Hosp, Barcelona, Spain
[4] Genentech Inc, San Francisco, CA 94080 USA
[5] F Hoffmann La Roche Ltd, Basel, Switzerland
[6] UTHealth, McGovern Med Sch, Houston, TX USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2017年 / 23卷
基金：
新加坡国家研究基金会;
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P676
引用
收藏
页码：324 / 325
页数：2
相关论文
共 50 条
  • [1] Safety of ocrelizumab in multiple sclerosis: updated analysis in patients with relapsing and primary progressive multiple sclerosis
    Hauser, S. L.
    Kappos, L.
    Montalban, X.
    Craveiro, L.
    Hughes, R.
    McNamara, J.
    Pradhan, A.
    Wormser, D.
    Koendgen, H.
    Wolinsky, J. S.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 317 - 318
  • [2] Safety of Ocrelizumab in Multiple Sclerosis: Updated Analysis in Patients With Relapsing and Primary Progressive Multiple Sclerosis
    Hauser, Stephen L.
    Kappos, Ludwig
    Montalban, Xavier
    Craveiro, Licinio
    Hughes, Richard
    Prajapati, Kalpesh
    Koendgen, Harold
    Pradhan, Ashish
    Wolinsky, Jerry S.
    NEUROLOGY, 2020, 94 (15)
  • [3] Safety of Ocrelizumab in Multiple Sclerosis: Updated Analysis in Patients With Relapsing and Primary Progressive Multiple Sclerosis
    Hauser, S. L.
    Kappos, L.
    Montalban, X.
    Craveiro, L.
    Hughes, R.
    Prajapati, K.
    Koendgen, H.
    Pradhan, A.
    Wolinsky, J. S.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 331 - 331
  • [4] Safety of Ocrelizumab in Multiple Sclerosis: Updated Analysis in Patients With Relapsing and Primary Progressive Multiple Sclerosis
    Hauser, Stephen
    Kappos, Ludwig
    Montalban, Xavier
    Koendgen, Harold
    Li, Carrie
    Marcillat, Carole
    Pradhan, Ashish
    Wormser, David
    Wolinsky, Jerry
    NEUROLOGY, 2018, 90
  • [5] Safety of Ocrelizumab in Multiple Sclerosis: Updated Analysis in Patients With Relapsing and Primary Progressive Multiple Sclerosis
    Hauser, Stephen L.
    Kappos, Ludwig
    Montalban, Xavier
    Chognot, Cathy
    Jessop, Nikki
    Pradhan, Ashish
    Prajapati, Kalpesh
    Wolinsky, Jerry S.
    NEUROLOGY, 2021, 96 (15)
  • [6] Safety of ocrelizumab in multiple sclerosis: Updated analysis in patients with relapsing and primary progressive multiple sclerosis
    Hauser, Stephen L.
    Kappos, Ludwig
    Montalban, Xavier
    Guittari, Carol-Jean
    Koendgen, Harold
    Li, Carrie
    Marcillat, Carole
    Wormser, David
    Wolinsky, Jerry
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 (02) : NP13 - NP13
  • [7] Safety of ocrelizumab in multiple sclerosis: updated analysis in patients with relapsing and primary progressive multiple sclerosis
    Hauser, S. L.
    Kappos, L.
    Montalban, X.
    Hughes, R.
    McNamara, J.
    Pradhan, A.
    Wormser, D.
    Koendgen, H.
    Wolinsky, J. S.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 239 - 239
  • [8] Safety of ocrelizumab in multiple sclerosis: Updated analysis in patients with relapsing and primary progressive multiple sclerosis
    Hauser, Stephen
    Kappos, Ludwig
    Montalban, Xavier
    Chognot, Cathy
    Jessop, Nikki
    Kadner, Karen
    Pradhan, Ashish
    Incera, Elodie
    Wolinsky, Jerry
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 352 - 353
  • [9] Safety of ocrelizumab in multiple sclerosis: updated analysis in patients with relapsing and primary progressive multiple sclerosis
    Hauser, S.
    Kappos, L.
    Montalban, X.
    Chognot, C.
    Craveiro, L.
    Pradhan, A.
    Prajapati, K.
    Wolinsky, J.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 306 - 306
  • [10] Safety of ocrelizumab in multiple sclerosis: Updated analysis in patients with relapsing and primary progressive multiple sclerosis
    Hauser, S. L.
    Kappos, L.
    Montalban, X.
    Chognot, C.
    Jessop, N.
    Kadner, K.
    Pradhan, A.
    Prajapati, K.
    Wolinsky, J. S.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 354 - 355
12345